POC hemoglobin analyzer
June 2018—EKF Diagnostics announced FDA 510(k) clearance and CLIA waiver for its DiaSpect handheld hemoglobin analyzer.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
June 2018—EKF Diagnostics announced FDA 510(k) clearance and CLIA waiver for its DiaSpect handheld hemoglobin analyzer.
June 2018—Curetis has been granted de novo clearance by the FDA to market the Unyvero System and Lower Respiratory Tract Infection Application Cartridge in the U.S.
June 2018—MDxHealth announced that its ConfirmMDx is included in the 2018 European Association of Urology guidelines. Inclusion in the guidelines will facilitate adoption of the test in EU member state-specific guidelines, and the company will pursue CE marking of the test.
June 2018—Enzo Life Sciences introduced three clinically relevant antibodies for immunohistochemistry detection.
June 2018—Nova Biomedical has opened a sales and after-sales support subsidiary in the canton of Zug, outside of Zurich.
June 2018—Thermo Fisher Scientific has signed agreements with Daiichi Sankyo and Takeda Pharmaceuticals designed to expand the clinical utility of Oncomine Dx Target Test in support of clinical trials and drug development programs at the Japanese companies.
June 2018—Sanquin and Abbott announced they signed a multiyear contract for the supply of primary serological equipment and consumables, including Abbott’s Alinity s system, for blood and plasma screening.
June 2018—LGC Maine Standards released its Validate Body Fluids, a comprehensive body fluids kit for linearity and calibration verification.
June 2018—The FDA has granted a de novo request to Dexcom for its Dexcom G6 integrated continuous glucose monitoring system for determining blood glucose levels for people with diabetes ages two and older.
June 2018—MilliporeSigma launched its CellStream flow cytometry system at the CYTO 2018 conference, April 28–May 2, in Prague. The CellStream is a benchtop, customizable flow cytometer that uses a camera for detection.